Company Update: Medtronic Inc (NYSE:MDT) – Medtronic Receives FDA Approval for Attain Performa® Quadripolar Lead and Viva® Quad CRT-Ds in United States

[Thomson Reuters ONE] – New System Helps Physicians Deliver Cardiac Resynchronization Therapy Optimally and Efficiently to Heart Failure Patients MINNEAPOLIS – Aug. 7, 2014 – Medtronic, Inc. (NYSE: MDT) today announced it has . . . → Read More: Company Update: Medtronic Inc (NYSE:MDT) – Medtronic Receives FDA Approval for Attain Performa® Quadripolar Lead and Viva® Quad CRT-Ds in United States Similar Articles: Company Update (NYSE:MDT): Medtronic Launches NuVent(TM) EM Sinus Dilation System for Fusion® ENT Navigation System Medtronic Inc (NYSE:MDT) – Medtronic Completes Acquisition of Visualase, Inc. Company Update (NYSE:MDT): Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in Europe